Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Agile Therapeutics (AGRX)
:AGRX
Holding AGRX?
Track your performance easily
AGRX Stock Chart & Stats
Day’s RangeN/A
52-Week Range― - ―
Previous CloseN/A
VolumeN/A
Average Volume (3M)N/A
Market Cap
N/A
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
BetaN/A
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Agile Therapeutics News
PremiumCompany Announcements
Agile Therapeutics Embarks on New Chapter Post-Merger
PremiumCompany Announcements
Agile Therapeutics Merges with Insud Pharma Subsidiary
PremiumCompany Announcements
Agile Therapeutics Releases Updated Investor Presentation
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
AGRX FAQ
What was Agile Therapeutics’s price range in the past 12 months?
Currently, no data Available
What is Agile Therapeutics’s market cap?
Currently, no data Available
When is Agile Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Agile Therapeutics’s earnings last quarter?
Currently, no data Available
Is Agile Therapeutics overvalued?
According to Wall Street analysts Agile Therapeutics’s price is currently Undervalued.
Does Agile Therapeutics pay dividends?
Agile Therapeutics does not currently pay dividends.
What is Agile Therapeutics’s EPS estimate?
Agile Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Agile Therapeutics have?
Currently, no data Available
What happened to Agile Therapeutics’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Agile Therapeutics?
Currently, no hedge funds are holding shares in AGRX
---
---